Evidence map›Paper›PMID 26902123›Full record

ReviewThe Journal of investigative dermatology2016

Research Progress in Pseudoxanthoma Elasticum and Related Ectopic Mineralization Disorders.

Qiaoli Li, Tamás Arányi, András Váradi, Sharon F Terry, Jouni Uitto

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of investigative dermatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Pseudoxanthoma elasticum.Orphanet journal of rare diseases · 2017
    Review
  15. Article
  16. Review
  17. Article
  18. Mouse genome-wide association study identifies polymorphisms on chromosomes 4, 11, and 15 for age-related cardiac fibrosis.Mammalian genome : official journal of the International Mammalian Genome Society · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Qiaoli LiDepartment of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Tamás ArányiInstitute of Enzymology, RCNS, Hungarian Academy of Science, Budapest, Hungary.
András VáradiInstitute of Enzymology, RCNS, Hungarian Academy of Science, Budapest, Hungary.
Sharon F TerryPXE International, Washington, DC, USA.
Jouni UittoDepartment of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Electronic address: Jouni.Uitto@jefferson.edu.
Institute of Molecular Life Sciences · HUThomas Jefferson University · US

Funding

Model Systems for PXER01AR055225 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI UITTO, JOUNI · 2008 to 2017
$3.2M
Modifier Genes for Ectopic MineralizationK01AR064766 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI LI, QIAOLI · 2014 to 2018
$634k
NIAMS NIH HHS K01 AR064766NIAMS NIH HHS R01 AR055225
6 · The paper itself

Abstract

Heritable ectopic mineralization disorders represent a phenotypically diverse group of conditions characterized by deposition of calcium phosphate complexes in soft connective tissues. The prototype of such conditions is pseudoxanthoma elasticum, and related conditions with overlapping clinical features include generalized arterial calcification of infancy and arterial calcification due to CD73 deficiency. Molecular genetic investigations have revealed mutations in the genes physiologically involved in generation of inorganic pyrophosphate and inorganic phosphate, and the findings suggest a unifying pathomechanism relating to reduced inorganic pyrophosphate/inorganic phosphate ratio. This hypothesis is based on the notion that inorganic pyrophosphate serves as a powerful inhibitor of mineralization, whereas inorganic phosphate is a promineralization factor, and an appropriate inorganic pyrophosphate/inorganic phosphate ratio is critical for prevention of ectopic mineralization under homeostatic conditions.

Indexed as

5'-NucleotidaseAnimalsBiomedical ResearchDiphosphatesForecastingGenetic Predisposition to DiseaseGPI-Linked ProteinsHumansMiceMice, KnockoutMolecular BiologyMutationPhenotypePseudoxanthoma ElasticumRare DiseasesVascular Calcification5'-NucleotidaseDiphosphatesdiphosphoric acidGPI-Linked ProteinsNT5E protein, human

Identifiers

PMID26902123
PMCPMC4765001
OpenAlexW2283362891

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.